V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10005007 | 10003129 | 1.56 | 50.8 | Palliative (P) | 2017-10-28 | 2017-11-18 | Palbociclib | N | N | 10559274 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10005008 | 10006773 | 1.73 | null | Palliative (P) | 2018-08-08 | 2018-08-09 | CISPLATIN + FLUOROURACIL | N | null | 10559300 | ETOPOSIDE |
| 10005009 | 10006773 | 1.79 | 70 | Adjuvant (A) | 2018-07-17 | 2018-07-19 | CISPLATIN + GEMCITABINE + RITUXIMAB | 2 | N | 10559300 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 10005010 | 10006773 | 1.65 | null | Curative (C) | 2018-04-06 | 2018-04-25 | Cetuximab + Oxaliplatin + MdG Load | N | null | 10559300 | VINORELBINE |
| 10005011 | 10003130 | null | 85.45 | Curative (C) | 2018-04-19 | 2018-04-27 | CISPLATIN + FLUOROURACIL | N | N | 10559415 | SORAFENIB |
| 10005012 | 10003130 | 1.75 | null | Neo-adjuvant (N) | 2017-02-08 | 2017-02-23 | RUXOLITINIB | Y | N | 10559415 | RUXOLITINIB |
| 10005013 | 10003131 | 1.76 | 79.6 | Palliative (P) | 2017-06-11 | 2017-06-11 | Doxorubicin chemoembolisation | 2 | N | 10559587 | CHLORAMBUCIL + RITUXIMAB |
| 10005014 | 10003132 | 1.76 | null | Disease modification (D) | 2017-06-16 | 2017-06-25 | Sorafenib | N | null | 10559669 | VINORELBINE |
| 10005015 | 10003133 | 1.7 | 61.4 | Palliative (P) | 2014-08-20 | 2014-08-21 | Capecitabine (21days) + Carboplatin | Y | null | 10559741 | LOMUSTINE + PROCARBAZINE + VINCRISTINE |
| 10005016 | 10003134 | 0 | 72.4 | Palliative (P) | 2019-03-11 | 2019-03-17 | ETOPOSIDE | N | N | 10559798 | DABRAFENIB |
| 10005017 | 10003135 | 0 | 67.4 | Adjuvant (A) | 2017-02-09 | 2017-02-09 | Cisplatin + Docetaxel +Fluorouracil | Y | N | 10559809 | DOXORUBICIN + GEMCITABINE |
| 10005018 | 10003136 | 1.75 | null | Palliative (P) | 2017-12-14 | 2017-12-17 | IPILIMUMAB + NIVOLUMAB | N | N | 10559866 | IBRUTINIB |
| 10005019 | 10003137 | 1.6 | 85 | Neo-adjuvant (N) | 2016-01-09 | 2016-01-10 | LENALIDOMIDE | N | null | 10559876 | ERLOTINIB |
| 10005020 | 10003138 | null | 72.2 | Palliative (P) | 2016-07-13 | 2016-07-26 | CYTARABINE | 02 | N | 10560079 | CHLORAMBUCIL + RITUXIMAB |
| 10005021 | 10003139 | 0 | 0 | Curative (C) | 2016-01-29 | 2016-02-01 | Sunitinib | N | N | 10560113 | TEMOZOLOMIDE |
| 10005022 | 10003140 | 1.71 | null | Adjuvant (A) | 2017-01-05 | 2017-01-05 | CARBOPLATIN + RT | 02 | N | 10560136 | NIVOLUMAB |
| 10005023 | 10003140 | null | 102.1 | Palliative (P) | 2016-02-08 | 2016-02-08 | Ipilimumab | N | N | 10560136 | IPILIMUMAB + NIVOLUMAB |
| 10005024 | 10008249 | 1.78 | 64.9 | Neo-adjuvant (N) | 2015-11-23 | 2016-01-11 | Bendamustine +/- Prednisolone | null | Y | 10560217 | IPILIMUMAB + NIVOLUMAB |
| 10005025 | 10003141 | null | 60 | Palliative (P) | 2016-02-21 | 2016-02-29 | MELPHALAN | 02 | N | 10560233 | IPILIMUMAB |
| 10005026 | 10003142 | null | 105.7 | Palliative (P) | 2015-07-22 | 2015-07-22 | Cetuximab + Radiotherapy Load | 02 | N | 10560291 | GEFITINIB |
| 10005027 | 10003142 | 1.72 | null | Palliative (P) | 2017-09-19 | 2017-10-16 | IBRUTINIB | null | null | 10560291 | DA |
| 10005028 | 10003142 | 1.82 | 104.5 | Neo-adjuvant (N) | 2018-05-27 | 2018-06-06 | BORTEZOMIB + THALIDOMIDE | N | N | 10560291 | CHLVPP |
| 10005029 | 10003143 | null | null | Disease modification (D) | 2017-03-21 | 2017-03-21 | LENALIDOMIDE | N | N | 10560456 | IPILIMUMAB |
| 10005030 | 10003143 | 1.56 | 56 | Palliative (P) | 2015-03-20 | 2015-03-22 | IBRUTINIB | N | N | 10560456 | PAZOPANIB |
| 10005031 | 10003144 | 1.53 | 62 | Palliative (P) | 2016-07-26 | 2016-07-26 | Capecitabine + Streptozocin | N | N | 10560786 | DENOSUMAB + ERIBULIN |
| 10005032 | 10003145 | 1.92 | 98 | Palliative (P) | 2017-07-31 | 2017-08-01 | IPILIMUMAB + NIVOLUMAB | N | N | 10560818 | CLADRIBINE |
| 10005033 | 10003146 | 1.74 | 74.9 | Palliative (P) | 2015-06-20 | 2015-07-05 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 10561021 | CYTARABINE |
| 10005034 | 10003147 | 1.78 | 63 | Palliative (P) | 2018-06-14 | 2018-06-24 | ACELARATE Trial | N | N | 10561026 | MITOMYCIN INTRAVESICULAR |
| 10005035 | 10003148 | 1.58 | 106 | Palliative (P) | 2016-06-11 | 2016-06-25 | RCEOP | 2 | N | 10561139 | ENRICH TRIAL |
| 10005036 | 10003149 | 1.7 | 98.3 | Palliative (P) | 2015-09-20 | 2015-09-20 | CHLORAMBUCIL + RITUXIMAB | 2 | null | 10561219 | VEMURAFENIB |
| 10005037 | 10006778 | 0 | 60 | Neo-adjuvant (N) | 2016-02-09 | 2016-02-09 | CISPLATIN + FLUOROURACIL | N | N | 10561400 | GEFITINIB |
| 10005038 | 10006778 | 1.79 | null | Neo-adjuvant (N) | 2017-05-31 | 2017-06-07 | Methotrexate High Dose (3g/m2) | N | N | 10561400 | MPT |
| 10005039 | 10003150 | 1.72 | 110 | Not known (9) | 2018-01-22 | 2018-01-22 | Cytarabine Low Dose | N | null | 10561596 | TEMOZOLOMIDE |
| 10005040 | 10006779 | 1.77 | 72.6 | Palliative (P) | 2017-11-18 | 2017-12-23 | Mitomycin Intravesical | 2 | N | 10561987 | CHLORAMBUCIL + OBINUTUZUMAB |
| 10005041 | 10006779 | 1.58 | 93.3 | Palliative (P) | 2018-05-23 | 2018-05-23 | ACELARATE Trial | 02 | Y | 10561987 | SORAFENIB |
| 10005042 | 10006779 | 1.72 | 82.4 | Palliative (P) | 2017-02-15 | 2017-02-16 | Sunitinib | 2 | N | 10561987 | LENALIDOMIDE |
| 10005043 | 10003151 | null | 69.9 | Curative (C) | 2018-02-17 | 2018-02-17 | Capecitabine + Cisplatin + RT | N | N | 10562289 | CAP + RT |
| 10005044 | 10003152 | null | null | Neo-adjuvant (N) | 2017-06-21 | 2017-06-21 | Bendamustine +/- Prednisolone | null | N | 10562415 | RUXOLITINIB |
| 10005045 | 10003153 | 1.85 | 86.4 | Palliative (P) | 2016-12-13 | 2016-12-13 | Cetuximab 14 day | 02 | N | 10562448 | GEFITINIB |
| 10005046 | 10003153 | null | null | Disease modification (D) | 2018-07-10 | 2018-07-10 | Pazopanib | N | null | 10562448 | IPILIMUMAB + NIVOLUMAB |
| 10005047 | 10003154 | 1.5 | 84.1 | Curative (C) | 2017-04-18 | 2017-04-18 | DOXORUBICIN | N | N | 10562676 | TEMOZOLOMIDE |
| 10005048 | 10003155 | 1.71 | 102 | Palliative (P) | 2014-04-05 | 2014-04-05 | IDELALISIB + RITUXIMAB | 2 | N | 10562706 | PAD |
| 10005049 | 10003155 | 1.63 | 63.2 | Curative (C) | 2018-07-14 | 2018-07-20 | LENALIDOMIDE | N | N | 10562706 | MITOMYCIN INTRAVESICULAR |
| 10005050 | 10003155 | null | 61 | Palliative (P) | 2017-06-08 | 2017-06-08 | BUSULFAN | N | N | 10562706 | GEMCITABINE + PACLITAXEL |
| 10005051 | 10003156 | 1.67 | 102 | Palliative (P) | 2016-11-15 | 2016-11-15 | RITUXIMAB + prednisolone + VINBLASTINE + prednisolone | N | N | 10563076 | VISMODEGIB |
| 10005052 | 10003157 | 1.71 | null | null | 2015-04-23 | 2015-04-23 | R Chlorambucil | 1 | null | 10563102 | IBRUTINIB |
| 10005053 | 10003158 | 1.72 | 85.8 | Disease modification (D) | 2017-09-03 | 2017-09-06 | Cyclophosphamide + Dex + Rituximab | N | N | 10563143 | MPT |
| 10005054 | 10003158 | 1.65 | 50 | Adjuvant (A) | 2016-06-15 | 2016-06-16 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 10563143 | DABRAFENIB + TRAMETINIB |
| 10005055 | 10003159 | 1.83 | 55.7 | Palliative (P) | 2016-12-01 | 2016-12-06 | ANAGRELIDE | N | N | 10563242 | HCX |
| 10005056 | 10006783 | 1.93 | 87.4 | Disease modification (D) | null | 2014-03-12 | Ipilimumab | N | N | 10563295 | TEMOZOLOMIDE |